NexImmune, Inc. (NEXI)
OTCMKTS
· Delayed Price · Currency is USD
0.100
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
NexImmune Market Cap
NexImmune has a market cap or net worth of $139.47 thousand as of February 21, 2025. Its market cap has decreased by -94.17% in one year.
Market Cap
139.47K
Enterprise Value
-2.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 139.47K, a decrease of -99.97%. That is a compound annual growth rate of -87.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2025 | 139.47K | -13.08% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.16B |
| SS Innovations International | 1.72B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 919.08M |
| Elite Pharmaceuticals | 509.35M |
| Glass House Brands | 488.30M |
| Northwest Biotherapeutics | 333.35M |
| CytoDyn | 290.99M |